1)  nicomol
尼可莫尔
1.
An improved synthetic route of nicomol was introduced in the thesis.
介绍了合成治疗高脂血症的烟酸类药物尼可莫尔的合成路线 ,本路线采用了一勺烩的方法 ,简化了操作 ,总收率为 5 9%。
2)  nicorandil
尼可地尔
1.
Determination of Nicorandil Based on Its Polarographic Catalytic Wave;
尼可地尔的极谱催化波法测定
2.
Determination of Nicorandil Based on Cation Surfactant Enhancement by Single Sweep Oscillopolarography;
表面活性剂增敏单扫描示波极谱法测定尼可地尔
3.
Effects of ischemic postconditioning and preconditioning induced by Nicorandil on myocardial ischemia/reperfusion injury in isolated rat heart;
尼可地尔后处理联合预处理对离体心肌缺血/再灌注的作用研究
3)  nikethamide
尼可刹米
1.
Role of 5-HT_(2A) receptor in increase in respiratory-related rhythmic discharge activity by nikethamide in neonatal rat transverse medullary slices;
5-HT_(2A)受体在尼可刹米增强新生大鼠延髓脑片呼吸放电中的作用
2.
The effect of nikethamide on rabbit s pupils;
尼可刹米对实验家兔瞳孔的影响
4)  nicorandil
尼可的尔
1.
Results Glibenclamide 3mg/kg can induce coronary artery oscil lation,and this phenomenon expressed by thin artery strongly;the oscillation can ’t be restrained by nitroglycerin,but can be terminated by nicorandil.
方法 用优降糖诱发冠状动脉震颤后分别用尼可的尔、硝酸甘油观察两药对震颤的影响。
2.
Objective To investigate the effects of adenosine triphosphate-sensitive potassium (K + ATP ) channel opener nicorandil (Nic), K + ATP inhibitor glibenclamide (Gli) and voltage gated potassium (K + V) channel inhibitor 4-aminopyridine (4-AP) on the morphine (Mor) antinociception during intrathecal administration in rats.
随机每 5只 SD大鼠为一组于术后第 7天经导管蛛网膜下腔分别注射 10 μL下列药物 :K+ ATP通道开放剂尼可的尔 (Nic) 5 μg、K+ ATP通道抑制剂格列本脲 (Gli) 2 μg、K+ V 通道抑制剂 4 -氨基吡啶 (4 - AP)2μg、吗啡 (Mor) 5μg、 Nic 5μg+Mor 5μg、 Gli 2μg+Mor 5μg、 4 - AP 2μg+Mor 5μg或等量盐水 (Sal)。
5)  Citicoline sodium
尼可林
6)  Damping-adjustable
阻尼可调
1.
Comparison and Analysis of Damping-adjustable Shock Absorber;
汽车阻尼可调减振器比较分析
参考词条
补充资料:尼可莫尔
分子式:
CAS号:

性质:又称尼古模。为白色结晶性粉末,无味,无臭。熔点180~184℃。在水、乙醇、乙醚中难溶,溶于氯仿,易溶于1mol/L盐酸溶液。由3-酰氯吡啶为原料制得。本品具有降低胆固醇作用,抑制胆固醇吸收,促进其降解和排泄,并有降低血浆中甘油三酯水平之作用。用于治疗高脂血症。制剂为片剂。

说明:补充资料仅用于学习参考,请勿用于其它任何用途。